Cervical cancer vaccine to launch in a few months, priced between ₹200-400: Adar Poonawalla
Adar Poonawalla stated that the vaccine would first be accessible through the government channel and beginning next year, private partners would be included as well.
SII's Adar Poonawalla said on 1 Sep that India's first indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine for the cervical cancer will be launched in a couple of months
He further said that the cervical cancer vaccine will be available to the people in an affordable price range of ₹200-400.
"The schemes like Ayushman Bharat have made us think about preventive healthcare & we can now afford it," said the Department of Biotechnology's lead in the matter.
"I believe that scientific efforts are often unrecognized and this event is to celebrate that," he said.
Poonawalla stated that 200 million doses have been planned and that the vaccine will first be given to citizens of India before it is exported to other countries.
Cervical cancer is the second most common cancer among women in India between the ages of 15 and 44.
In July, the Drugs Controller General of India (DCGI) granted market authorization to the SII to manufacture a vaccine against cervical cancer.